July 30 2019, 5:05 p.m.
KAMALA HARRIS’S PRESIDENTIAL
CAMPAIGN, while releasing a new health care proposal yesterday, balked
at criticism that private industry interests would seek to
influence her election effort.
Ian Sams, the national press
secretary for the Harris campaign, told CNN on Monday that Harris “is not taking
any money from pharmaceutical executives.”
Federal Election Commission
campaign finance records, however, show that the California senator has
received thousands of dollars from executives at drug companies this
year, most of which has not been returned.
Donors include Therese Meaney,
a vice president at Endo Pharmaceuticals, a company that manufacturers opioid
painkillers, who has given $1,250 to
the Harris campaign; Ted Love, the president and chief executive of Global
Blood Therapeutics, a startup biopharmaceutical company, who gave $2,800;
J. Dana Hughes, a vice president at Pfizer, gave $250; Damian
Wilmot, an executive at Vertex Pharmaceuticals, gave $1,000;
and Jeffrey Stein, the chief executive of Cidara Therapeutics, another drug
startup, who gave $1,000.
There has been some effort by
the Harris campaign to return drug company money. Records show the
campaign returned a
$2,700 donation from John Guthrie, an executive at Pharmaceutics
International Inc., in March, for example. Why some drug company donations were
accepted and returned, while others were not, is not immediately clear.
During his remarks, Sams
swiped at the Bernie Sanders campaign, suggesting that the demand by Sanders
that candidates reject drug and insurance money is hypocritical because Sanders
also “took some money from pharmaceutical companies before he gave it
back.” Sams added that the donations “blurs the line of what the actual issue
is here.” The Sanders campaign returned donations from employees at drug
companies last month when they were flagged by
ABC News.
In an email, Sams reiterated
that the campaign does not accept drug company executive money. Sams said the
campaign had already returned the donations from Meaney and Stein, though he
did not say when the money was returned. Many of the donations, including
donations by Meaney and Hughes, were made early in the year —
and were not refunded in either the first or second quarter filings. Sams also
said the campaign is in the process of returning the donation
from Global Blood Therapeutics’ executive. He did not address the other
donations.
No comments:
Post a Comment